Objective:

To present early results of a new targeted therapy for head and neck cancer patients with specific protein marker expression.

Approach:

• Study Design: The study tested a targeted therapy for patients whose tumors express a specific protein marker associated with poor outcomes.

Key Findings:

• The treatment showed positive responses in patients with the specific protein marker, as reported by Victoria Villaflor, MD.
• Encouraging results were observed even in patients who had undergone multiple prior treatments.

Interpretation:

Conclusion:

The findings indicate early results for treatment in head and neck cancer patients with limited options.

Sources:

• ASCO 2026 Presentation